Krause Kevin Michael

CIK 00019169251 companyMENLO PARK, CA

Transactions

Companies

Filings

CIK

0001916925

Recent Transactions

13 trades

Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-03-15+60,000→ 60,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+30,000→ 31,914 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+30,000→ 31,914 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-09$0.42/sh+2,417→ 4,331 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-01-09−5,000→ 26,832 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-01-09−2,417→ 49,868 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-09$6.60/sh+5,000→ 9,331 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-09$20.14/sh−7,417→ 1,914 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-02$20.12/sh−2,583→ 1,914 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-01-02−2,583→ 52,285 total
Exercise/Conversion
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-02$0.42/sh+2,583→ 4,497 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-02-15+62,200→ 62,200 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 total

C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D

MENLO PARK, CA, 94027